CEO Heejoon Myung gave a lecture titled “Bacteriophages and Endolysins for Treating Multidrug-Resistant Bacteria” at the Korean Society of Infectious Diseases Fall Conference held on November 3, 2023 (https://www.ksid.or.kr/abstract/2023_fall/main.html). The explosion of antibiotic-resistant superbugs and the depletion of the pipeline of new antibiotics are raising the possibility of the next pandemic. He introduced global research trends and in-house data on new antibiotics using bacteriophages and endolysins being developed by LyseNTech.